Sino Biopharmaceutical reported CNY7.54B in Selling and Administration Expenses for its fiscal semester ending in June of 2025.





Selling And Administration Expenses Change Date
Akebia Therapeutics USD 23.53M 3.19M Dec/2025
Alaunos Therapeutics USD 447K 138K Mar/2026
Avita Medical AUD 19.03M 1.95M Dec/2025
Cspc Pharmaceutical CNY 1.87B 95.62M Dec/2025
Dianthus Therapeutics USD 12.47M 5.89M Mar/2026
Ionis Pharmaceuticals USD 130.07M 20.92M Jun/2026
IQVIA Holdings USD 574M 72M Jun/2026
Jiangsu Hengrui CNY 2.78B 30.09M Jun/2026
Moderna USD 216M 43M Jun/2026
Organon & Co USD 434M 10M Jun/2026
Revvity USD 278.58M 24.69M Jun/2026
Sino Biopharmaceutical CNY 7.54B 2.23B Jun/2025
Tectonic Therapeutic USD 6.43M 2.99M Mar/2026
Viatris USD 1.13B 205.7M Jun/2026
Xeris Pharmaceuticals USD 53.14M 10.51M Mar/2026